Echo Therapeutics (OTC: ECTE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Echo Therapeutics (OTC: ECTE) through any online brokerage.
There are no as such competitors for Echo Therapeutics.
The latest price target for Echo Therapeutics (OTC: ECTE) was reported by Feltl & Co. on Tuesday, November 26, 2013. The analyst firm set a price target for 9.35 expecting ECTE to rise to within 12 months (a possible 4674900.00% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Echo Therapeutics (OTC: ECTE) is $0.0002 last updated September 2, 2021, 7:12 PM UTC.
There are no upcoming dividends for Echo Therapeutics.
Echo Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Echo Therapeutics.
Echo Therapeutics is in the Healthcare sector and Medical Devices industry. They are listed on the OTC.